Growth potential Ellume is a hardware-focused health tech company with plans to scale headcount and manufacturing; potential sales opportunities exist in expanding diagnostics manufacturing capabilities, connected care platforms, and enterprise-grade data integration solutions to support higher volume production and global distribution.

Partnership leverage Recent and ongoing partnerships, including with Qiagen for TB diagnostics, indicate openness to co-development and distribution partnerships; opportunities exist to propose collaborative development, contract manufacturing, or channel partnerships with complementary life sciences and molecular diagnostics players.

Connectivity play Ellume emphasizes connected real-time diagnostics and care technologies; upsell possibilities include cloud-based data analytics, telemedicine integration, and secure IoT-enabled enablement for clinics and consumer testing with actionable patient insights.

Regulatory readiness With prior FDA engagement and EUA milestones alongside past recalls, there is a need for robust quality management, manufacturing excellence, and regulatory compliance services; potential to offer quality systems, device safety analytics, and post-market surveillance solutions.

Global expansion Australian origin with international partnerships and ambitions suggests opportunities to support market entry services, local manufacturing support, and regional compliance solutions as Ellume scales beyond Australia and the US toward broader global distribution.